BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3519278)

  • 1. [Results of the experimental study and clinical use of the tranquilizer mebikar].
    Kamburg RA; Zaikonnikova IV
    Farmakol Toksikol; 1986; 49(2):89-91. PubMed ID: 3519278
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanisms of the antishock action of mebikar].
    Zimakova IE; Bazarevich GIa; Kamburg RA; Nizamutdinov EZ
    Farmakol Toksikol; 1984; 47(2):28-32. PubMed ID: 6714398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of the tranquilizer mebikar for treating climacteric neuropsychic disorders].
    Mendelevich DM; Zimakova IE; Mendelevich VD
    Akush Ginekol (Mosk); 1983 Feb; (2):51-3. PubMed ID: 6846724
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mebikar in climacteric myocardiodystrophy].
    Zamotaev IP; Mkrtchian VR; Venediktova MG
    Sov Med; 1987; (8):57-60. PubMed ID: 3423965
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and experimental validation of the use of the tranquilizer mebikar as a corrective of the neuroleptic syndrome].
    Zimakova IE; Semenikhin DG; Karpov AM; Kirshin SV
    Farmakol Toksikol; 1988; 51(1):21-3. PubMed ID: 3360102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protective effect of the psychotropic preparations diazepam, sodium oxybutyrate and mebikar in experimental arrhythmias].
    Kamburg RA; Zimakova IE
    Farmakol Toksikol; 1982; 45(4):16-9. PubMed ID: 7128780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the nootropic effect of mebikar in clinical practice].
    Zimakova IE; Makarchikov NS; Karpov AM
    Farmakol Toksikol; 1986; 49(5):50-3. PubMed ID: 3770177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of the functionally disturbed heart with regard to its vascular and nervous supply].
    Leonard W
    Hippokrates; 1968 Jan; 39(2):69-72. PubMed ID: 5716576
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of mebikar on the experimental and clinical course of traumatic shock].
    Bazarevich GIa; Zimakova IE; Kharin GM; Katkovskiĭ GB; Lazareva LV
    Vestn Khir Im I I Grek; 1981 Jul; 127(7):81-5. PubMed ID: 7292861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An analysis of the cardiovascular reactions due to mebikar].
    Kamburg RA
    Farmakol Toksikol; 1990; 53(5):32-4. PubMed ID: 2253745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of mebikar on the state of animals under extreme conditions].
    Zimakova IE; Kamburg RA; Kirshin SV
    Farmakol Toksikol; 1980; 43(4):368-71. PubMed ID: 7439369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the effects of oxprenolol on pain and on electrocardiographic changes in patients with ischemic heart disease].
    Contino A
    G Clin Med; 1979 May; 60(5):402-8. PubMed ID: 488590
    [No Abstract]   [Full Text] [Related]  

  • 13. Antianginal drugs--a review.
    Rossi GV
    Am J Pharm Sci Support Public Health; 1971; 143(5):153-60. PubMed ID: 4945301
    [No Abstract]   [Full Text] [Related]  

  • 14. [The use of inderal in angina pectoris and arrhythmias].
    Krasnikov IuA
    Ter Arkh; 1967 Jul; 39(7):84-7. PubMed ID: 5610938
    [No Abstract]   [Full Text] [Related]  

  • 15. [Initial clinical results of N-(3-isoamyloxy, 2-(3,4,5-trimethoxy) benzoyloxy) propyl tetrahydro 1,4-oxazine hydrochloride on coronary pain and disorders of rhythm].
    Pernod J; Kermarec J
    Therapie; 1969; 24(4):675-82. PubMed ID: 5822249
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled clinical study of the use of creatinol-O-phosphate in subjects with deficient myocardial circulation].
    Guglielmi G; Mammarella A
    Clin Ter; 1979 Nov; 91(4):355-82. PubMed ID: 396100
    [No Abstract]   [Full Text] [Related]  

  • 17. [Psychopharmacological preparations in diseases of the cardiovascular system].
    Paleev NR; Raĭskiĭ VA
    Kardiologiia; 1976 Jul; 16(7):148-55. PubMed ID: 978876
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment with sidnonimine derivatives of chronic ischemic heart disease patients].
    Kuz'ko NV
    Vrach Delo; 1984 Jul; (7):79-81. PubMed ID: 6548063
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with a new cardiac sedative (Seda-Miroton)].
    Klein HG
    Med Welt; 1966 Jul; 30():1592-4. PubMed ID: 5927501
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical use of a combination of butydrine and pentaerythrol in coronary insufficiency].
    Ballerini A
    Minerva Cardioangiol; 1971 May; 19(5):272-6. PubMed ID: 4397515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.